+B: Data sources
The Clinical Practice Research Database (CPRD) is a primary care database containing diagnostic and prescription data for approximately 13 million people of the general population in the UK, with 3·4 million active patients contributing data. Diseases are coded within the CPRD using Read codes which have been used by clinicians to record data within primary care since 1985. 16 Hospital Episode Statistics (HES) collects a record for each episode of admitted patient care delivered in England, either by National Health Service (NHS) hospitals or delivered in the independent sector but commissioned by the NHS. It has collected data since 1989, with more than 15 million new records added each year. Records are coded using a combination of ICD-10 codes for diagnosis at discharge along with Office of Population, Censuses and
Surveys Classification of Surgical Operations and Procedures (OPCS 4) detailing procedures
performed. Increasingly HES data are being used to study surgical diseases, with a recent systematic review 17 reporting that approximately two-thirds of studies published using these data concern surgical conditions.
Death certificate data from the Office for National Statistics were also used.
Anonymized patient identifiers from CPRD and HES were linked by a trusted third party by using the NHS number, date of birth, postcode and sex. Most patients were matched exactly according to NHS number (over 90 per cent of patients are linked in this way), with the remaining patients linked probabilistically on the basis of postcode, date of birth and sex. In the version employed, 53.0 per cent of practices in the CPRD are linked to HES, representing a 3.0 per cent sample of the population of England. These data have been shown previously 18 to be similar in terms of age, sex and geographical distribution to data from the UK population.
+B: Cohort
The cohort was identified using OPCS codes for any colectomy from HES data between 2001
and 2011 (Appendix S1, supporting information). Operations confined to or including the rectum and anal canal were excluded. Person-time at risk commenced on the day after surgery for the overall analysis; therefore VTEs recorded on the same day as the operation were not included in the analysis. Patients were followed up until they developed a VTE event, died, left a participating general practice, or for 1 year after surgery. Patients were excluded if they were: not in a linked general practice or had had a VTE before the admission date for colectomy, as these patients have an inherently increased risk of postoperative VTE.
Previous VTE was defined using the same definition as for the entire study.
+B: Exposures
Patients were identified who had a colorectal cancer diagnosis in the CPRD and HES data (ICD-10 sections C18-20, excluding C18.1 Appendix). The non-malignant diagnoses were confirmed from the ICD-10 discharge codes associated with the admission, including inflammatory bowel disease (Appendix S1, supporting information), diverticular disease (Appendix S1) and other. Co-morbidity was determined from the CPRD and classified using the Charlson index before admission for surgery 19 . Admission type was defined as elective or emergency, based on the type of admission recorded for the surgical procedure. Smoking status was classified as never, ever, current or missing, based on CPRD smoking records before the operation. Body mass index (BMI) was recorded from CPRD records, and patients were classified as having a BMI of less than 30 kg/m 2 , 30 kg/m 2 or more, or missing data.
Laparoscopic surgery was defined as any surgery accompanied by a laparoscopic code.
Prescriptions for the oral contraceptive pill and hormone replacement therapy (HRT) were identified from the CPRD, and users were classified as current if the prescription was within 3 months of the index operation.
+B: Outcome definition
VTE diagnosis was determined from medical codes in the CPRD and HES. These were considered to indicate a valid VTE event if supported by either: a prescription for an anticoagulant or other evidence of treatment in an anticoagulation clinic (such as a medical code) between 15 days before and 90 days after the VTE diagnosis, or a date of death within 30 days of the event. Additionally, an underlying cause of death of VTE was included as evidence of a VTE diagnosis. The definition using primary care data alone has been validated previously 20 and used in the authors' previous studies of VTE 21, 22 .
+B: Statistical analysis
The date of diagnosis of VTE was taken to be the episode start date for VTEs occurring within the same hospital admission as the index operation. 
+B: Venous thromboembolism rates overall, by admission type and indication
The overall rate of VTE following colectomy for any indication was 29.59 (95 per cent c.i. 
+C: Emergency surgery
In the first month after discharge from hospital the absolute rate of VTE was lower following emergency admission for non-malignant disease compared with that in the first month after 
+A: Discussion
This study found an overall 1-year incidence of VTE following colectomy of 2.5 per cent.
The highest overall absolute rates of VTE occurred after emergency surgery for malignant disease, and rates increased with age for non-malignant indications, although not in patients with cancer. Undoubtedly, the period of greatest risk for VTE following colectomy is the first month after surgery: around 0.5 per cent by the end of this period following any colectomy, and 1.0 per cent with an emergency admission. Of particular note is the fact that patients undergoing emergency colectomy for either a malignant or a non-malignant indication had similar high rates of VTE in the early postoperative period. Given that current guidance recommends extending VTE prophylaxis following colectomy for malignancy to 28 days after surgery, randomized clinical trials of the benefits of extended prophylaxis may be warranted in those patients having an emergency colectomy for non-malignant disease.
This study used linked data to identify patients undergoing colectomy from populationbased data, with identification of operative procedures from secondary care along with defining VTE in a validated manner from primary 20 and secondary care, and is thus uniquely placed to quantify VTE risk accurately. The identification of VTE following discharge from hospital relies on clinical suspicion of the general practitioner and subsequent referral for investigation, thereby minimizing the surveillance bias that may occur in patients identified solely in hospital, as has been suggested in other studies 24 . The indication for surgery in patients with non-malignant disease was not classified specifically in 25.2 per cent of patients (1029 of 4079) and this figure is in keeping with data previously published using stand-alone HES data 25 . Furthermore, when these patients were excluded from the analysis, the absolute rates of VTE remained broadly similar, suggesting that the risk of VTE in these patients was no greater than that of patients with a clear indication for surgery. Although the authors were unable to identify patients who received thromboprophylaxis at or around the time of surgery during the study interval (2001-2011), only in the last year of the study were there recommendations for prolonged thromboprophylaxis following surgery in the UK. Uptake of this by colorectal surgeons at this time was poor 26 , so patients would at most have received low molecular weight heparin while an inpatient following surgery 15 .
The sensitivity analysis of patients following discharge demonstrates that patients were still at increased risk of VTE after discharge, regardless of whether they had received thromboprophylaxis in hospital. In addition, rates of thromboprophylaxis at this time were low, with the ENDORSE study 27 estimating that only 50 per cent of patients received appropriate thromboprophylaxis, with a lower proportion in those undergoing emergency surgery -in whom the present study found the highest absolute rates of VTE. Nevertheless the possibility cannot be excluded that rates of VTE might have been higher in some groups than was observed in this study, precisely because they received longer prophylaxis.
The potential effects of laparoscopic resection on the rates of VTE could not be assessed fully. Laparoscopic resection rates reported here were low, as it was during the study period that laparoscopic resection rates began to increase. The finding of approximately onethird of resections being performed laparoscopically by the end of the study is in keeping with data from the National Bowel Cancer Audit 28 . Further studies are required to assess the potential benefits of laparoscopic surgery in this group of patients.
Rates of VTE following a diagnosis of colorectal cancer were recently the subject of a systematic review and meta-analysis 29 2008 reported an overall VTE rate of 2.5 per cent following colectomy, with a postdischarge rate of 0.7 per cent, which is in keeping with the 0.5 per cent rate found in the present study for all patients following colectomy. Fleming and co-workers 31 found no difference in VTE rates between non-malignant and malignant disease (both 0.7 per cent), although they did not report rates according to whether surgery was performed as an emergency or electively. The present study, however, has shown a clear increased risk for malignant disease, of 2.4-fold in the first year after emergency surgery and 4.2-fold following elective surgery.
Few studies have reported the risk of VTE after surgery for non-malignant disease. A study 12 using data from the NSQIP database reported a 30-day risk of VTE following surgery for IBD of 2.3 per cent (242 of 10 431). This is higher than the 30-day rate for non-malignant disease in the present study; however, it is not clear whether Wallaert et al. 12 excluded patients who had had a VTE previously, as in the present study. Their study did, however, find that emergency surgery resulted in a 1.8-fold (odds ratio 1. prophylaxis. Given the findings of the ENDORSE study 27 , every effort should be made to assess risk in these patients before operation and ensure that appropriate thromboprophylaxis is prescribed during their hospital stay. Interventional studies assessing the benefit and risks of extended prophylaxis in patients undergoing emergency colectomy for non-malignant disease may be warranted. 
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